# Max Healthcare

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/max-healthcare/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 43.5 |
| Citations | 34,703 |
| City | New Delhi |
| Country | IN |
| Description | Max Healthcare is a research organisation in New Delhi, IN. OpenAlex records 1,939 works and 34,703 citations for it. 600 researchers list it as their most recent affiliation. |
| Homepage | https://www.maxhealthcare.in/ |
| OpenAlex ID | https://openalex.org/I307255591 |
| Researchers | 600 |
| ROR ID | https://ror.org/02vdjrg05 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q6794859 |
| Works | 1,939 |

## University papers

- [Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/finerenone-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/)
- [Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes](https://scholariq.org/papers/semaglutide-in-patients-with-obesity-related-heart-failure-and-type-2-diabetes/)
- [Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes](https://scholariq.org/papers/effect-of-dapagliflozin-on-worsening-heart-failure-and-cardiovascular-death-in/)
- [Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/efficacy-of-dapagliflozin-on-renal-function-and-outcomes-in-patients-with-heart/)
- [Empagliflozin after Acute Myocardial Infarction](https://scholariq.org/papers/empagliflozin-after-acute-myocardial-infarction/)
- [Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF](https://scholariq.org/papers/dapagliflozin-and-diuretic-use-in-patients-with-heart-failure-and-reduced/)

## University top topics

Showing 8 of 25.

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Hernia repair and management](https://scholariq.org/topics/hernia-repair-and-management/)
- [Total Knee Arthroplasty Outcomes](https://scholariq.org/topics/total-knee-arthroplasty-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.